Energy

Johnson & Johnson's unbroken history of taking minority equity stakes in third-party entrepreneurs marks it as one of the oldest and most consistent investors in corporate venturing, writes James Mawson

Healthcare corporations are filling a void left by retreating venture capital firms in their sector.

Crispin Leick from Innogy Ventures and Jules Kortenhorst from Topell provide a War Stories discussion.

Panel on why firms are raising so many funds, and so many are outside of the US? Stephen Ziff from Coller Capital moderated the panel.

Panel on the next generation of corporate venturing leaders, moderated by Neil Foster from Baker Botts.

Justin Adams, ex-head of Emerging Business and Ventures at BP, reflects on corporate venturing and its future models.

Panel on how can firms deal with a globally-distributed, cross-sectoral innovation landscape, moderated by Andrew Gaule from Corven.

Panel on the role of governments to help the ecosystem, moderated by Erik Vermeulen from Philips and Tilburg University Law School.

Global Corporate Venturing Panel Discussion on Venture Connectivity, moderated by Erik Sebusch from CMEA Capital.

As the founder of one of the firms that has just been backed said: "My theory is that any company able to hold out to 2014 will be a winner."